Product Directory — Diagnostics, Devices & Equipment

Silaris Image

Silaris

SEKISUI DIAGNOSTICS | Flu Tests

A molecular test utilizing polymerase chain reaction (PCR) technology providing accurate results for early diagnosis and proper management of influenza.

Silaris

SilarisTM Influenza A&B Test
The CLIA Waived SilarisTM Influenza A&B Test is a molecular diagnostic test utilizing polymerase chain reaction (PCR) technology providing accurate results for early diagnosis and proper management of influenza. Features and Benefits
  • Accurate Molecular PCR Results
    • Influenza A: Sensitivity 97% & Specificity 94%
    • Influenza B: Sensitivity 94% & Specificity 99%
  • Affordable
    • Definitive diagnosis (no confirmation required)
    • Controls included with each kit
  • SIMPLE
    • Simple three step procedure and minimal hands on time of <1 minute
    • No refrigeration required
Description Catalog# Configuration Storage Shelf Life
SilarisTMInfluenza A&B Test 1027 25 Test Room Temperature 18 months
SilarisTMInfluenza A&B Control Kit 1024 5 - A+/B- Control Swabs;5- A-/B+ Control Swabs Room Temperature 18 months
SilarisTMInfluenza A&B Starter Pack 1028 50 Tests;1 – Silaris Dock Room Temperature
SilarisTMDock 1026 1 - Dock Room Temperature 3000 Tests
View Brochures and Additional Information

SEKISUI DIAGNOSTICS

SEKISUI DIAGNOSTICS Logo

4 Hartwell Place | Lexington | MA | 02421 | US

For over 35 years Sekisui Diagnostics has been committed to providing innovative medical diagnostics to physicians and laboratories. We develop, manufacture, and supply billions of tests each year to the global healthcare market. Our product lines include clinical chemistry and coagulation systems and reagents, point-of-care molecular, rapid tests and immunoassay system as well as enzymes and specialty biochemicals.

BD Veritor System Image

BD Veritor System

BD DIAGNOSTICS | Flu Tests

BD - Diagnostic Systems: BD Veritor System: CLIA-waived For Rapid Detection of Flu A+B.

BD Veritor System


BD


BD Veritor ™ System CLIA-waived for Rapid Detection of Flu A+B meets the New FDA Requirements Our BD Veritor ™ line of immunoassay products, the BD Veritor ™ Plus System and the BD Veritor ™ System give healthcare providers and laboratorians in near patient settings the objective, lab-quality tests results at the point of care within minutes. This assay system eliminates the subjectivity of visual interpretations of tests results and replaces it with an objective digital result. BD Veritor ™ System – Proven Performance vs. Polymerase Chain Reaction (PCR)

  • PCR is currently the highest sensitivity standard available
BD Veritor System vs. PCR – Nasal Swab Results
BD BD
Convenient Workflow BD Changing The Way You View Rapid Testing BD

Educational Resources

BD DIAGNOSTICS

BD DIAGNOSTICS Logo

7 Loveton Circle | Sparks | MD | 21152 | US

BD - Diagnostic Systems: BD Veritor System: CLIA-waived For Rapid Detection of Flu A+B

cobas® Influenza A/B & RSV assay Image

cobas® Influenza A/B & RSV assay

ROCHE DIAGNOSTICS | Flu Tests

The cobas Influenza A/B & RSV assay is the first CLIA-waived, real-time PCR test that differentiates Influenza A, Influenza B and RSV in 20 minutes ...

cobas® Influenza A/B & RSV assay

cobas® Influenza A/B & RSV assay The cobas Influenza A/B & RSV assay is the first CLIA-waived, real-time PCR test that differentiates Influenza A, Influenza B and RSV in 20 minutes. It's available for use in hospitals, physician offices and urgent care settings. Benefits:

  • Lab-quality performance in the detection and differentiation of Influenza A, Influenza B and RSV strains
  • Fast results, 20-min. turnaround time
  • Simplicity—minimal hands-on time, walkaway test with easy results interpretation
  • Supports timely, confident treatment decisions

ROCHE DIAGNOSTICS

ROCHE DIAGNOSTICS Logo

9115 Hague Road Bldg. H | Indianapolis | IN | 46250 | US

Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways

cobas® Influenza A/B assay Image

cobas® Influenza A/B assay

ROCHE DIAGNOSTICS | Flu Tests

The cobas Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes ...

cobas® Influenza A/B assay

cobas® Influenza A/B assay The cobas® Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes. Available for use in non-traditional testing sites, including ERs, physician offices, pharmacy clinics and other urgent care settings. Benefits:

  • Lab-quality performance in the detection and differentiation of Influenza A and Influenza B
  • Fast results—20-min. turnaround time
  • Simplicity—minimal hands-on time, walk-away test with easy results interpretation
  • Supports timely, confident treatment decisions

ROCHE DIAGNOSTICS

ROCHE DIAGNOSTICS Logo

9115 Hague Road Bldg. H | Indianapolis | IN | 46250 | US

Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways